All Stories

  1. Article
    Vascular issues, muscle loss, and cognitive decline worsen with age. Integrated therapies may help.
    Dr. Masaru Tanaka
  2. Article
    Uncovering the Brain’s Hidden Patterns: Distinct Gray Matter Changes in Autism Revealed
    Dr. Masaru Tanaka
  3. Article
    Curcumin for Healthy Aging: A Natural Way to Combat Memory Loss, Muscle Decline, and Inflammation
    Dr. Masaru Tanaka
  4. Article
    The Indissociable Triad: Vascular Impairment, Muscle Atrophy, and Cognitive Decline
    Dr. Masaru Tanaka
  5. Article
    Exploring Dr. Heinz Reichmann’s Contributions to Parkinson's Disease Research and Treatment
    Dr. Masaru Tanaka
  6. Article
    Bridging the Gap: Understanding the Link between Blood Flow, Muscle Health, and Brain Function
    Dr. Masaru Tanaka
  7. Article
    Curcumin's Role in Promoting Healthy Aging: What the Research Says
    Dr. Masaru Tanaka
  8. Article
    Navigating the Neurobiology of Migraine: From Pathways to Potential Therapies
    Dr. Masaru Tanaka
  9. Article
    10th Anniversary of Biomedicines—Translational Laboratory and Experimental Medicine for the Sake of Neurological Diseases and Mental Illnesses
    Dr. Masaru Tanaka
  10. Article
    Ginkgo biloba: A Leaf of Hope in the Fight against Alzheimer’s Dementia: Clinical Trial Systematic Review
    Dr. Masaru Tanaka
  11. Article
    A Decade of Dedication: Pioneering Perspectives on Neurological Diseases and Mental Illnesses
    Dr. Masaru Tanaka
  12. Article
    Innovation at the Intersection: Emerging Translational Research in Neurology and Psychiatry
    Dr. Masaru Tanaka
  13. Article
    Oxidative and Excitatory Neurotoxic Stresses in CRISPR/Cas9-Induced Kynurenine Aminotransferase Knock-Out Mice: A Novel Model for Experience-Based Depression and Post-traumatic Stress Disordertabolism: Insights From Novel Kynurenine Aminotransferase
    Dr. Masaru Tanaka
  14. Article
    Innovation at the Intersection: Emerging Translational Research in Neurology and Psychiatry
    Dr. Masaru Tanaka
  15. Article
    Genetic, Epigenetic, Environmental, and Pharmacological Models for Neuroscience, Neurologic Diseases, and Psychiatric Disorders: Advancement in Bench-to-Bedside Translational Research
    Dr. Masaru Tanaka
  16. Article
    Neurodegeneration in Cognitive Impairment and Mood Disorders for Experimental, Clinical and Translational Neuropsychiatry
    Dr. Masaru Tanaka
  17. Article
    Ginkgo biloba: A Leaf of Hope in the Fight Against Alzheimer’s Dementia: Clinical Trial Systematic Review
    Dr. Masaru Tanaka
  18. Article
    Investigating the Neuroprotective and Cognitive-Enhancing Effects of Bacopa monnieri: A Systematic Review Focused on Inflammation, Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis
    Dr. Masaru Tanaka
  19. Article
    The Impact of C-3 Side Chain Modifications on Kynurenic Acid: A Behavioral Analysis of Its Analogs in the Motor Domain
    Dr. Masaru Tanaka
  20. Article
    From Lab to Life: Exploring Cutting-Edge Models for Neurological and Psychiatric Disorders
    Dr. Masaru Tanaka
  21. Article
    From Lab to Life: Exploring Cutting-Edge Models for Neurological and Psychiatric Disorders
    Dr. Masaru Tanaka
  22. Article
    Neurodegeneration in Cognitive Impairment and Mood Disorders for Experimental, Clinical and Translational Neuropsychiatry
    Dr. Masaru Tanaka
  23. Article
    Neural Correlates and Molecular Mechanisms of Memory and Learning
    Dr. Masaru Tanaka
  24. Article
    The Impact of C-3 Side Chain Modifications on Kynurenic Acid: A Behavioral Analysis of Its Analogs on Motor Domain
    Dr. Masaru Tanaka
  25. Article
    The Orexin/Hypocretin System, the Peptidergic Regulator of Vigilance, Orchestrates Adaptation to Stress
    Dr. Masaru Tanaka
  26. Article
    Neurodegeneration in Cognitive Impairment and Mood Dis-orders for Experimental, Clinical and Translational Neuropsy-chiatry
    Dr. Masaru Tanaka
  27. Article
    The Neuroprotective and Cognitive-Enhancing Effects of <em>Bacopa monnieri</em>: A Systematic Review
    Dr. Masaru Tanaka
  28. Article
    Master Regulators of Vigilance and Stress Response: The Intricate Involvement of Orexin/Hypocretin Neuropeptides in Physiology and Behavior
    Dr. Masaru Tanaka
  29. Article
    From CGRP to PACAP, VIP, and Beyond: Unraveling the Next Chapters in Migraine Treatment
    Dr. Masaru Tanaka
  30. Article
    Emerging Translational Research in Neurological and Psychiatric Diseases: From In Vitro to In Vivo Models
    Dr. Masaru Tanaka
  31. Article
    From CGRP to PACAP: Unraveling the Next Chapter in Migraine Treatment
    Dr. Masaru Tanaka
  32. Article
    Emerging Translational Research in Neurological and Psychiatric Diseases: From In Vitro to In Vivo Models
    Dr. Masaru Tanaka
  33. Article
    Exploring the Neurobiological Roots of Emotional Behavior in Tryptophan Metabolism: Insights from Novel Kynurenine Aminotransferase Knockout Mice
    Dr. Masaru Tanaka
  34. Article
    Exploring the Neurobiological Roots of Emotional Behavior in Tryptophan Metabolism: Insights from Novel Kynurenine Aminotransferase Knockout Mice
    Dr. Masaru Tanaka
  35. Article
    Unraveling the Neurobiological Roots of Despair: Insights from Novel Kynurenine Aminotransferase II Knockout Mice
    Dr. Masaru Tanaka
  36. Article
    From CGRP to PACAP: Unraveling the Next Chapter in Migraine Treatment
    Dr. Masaru Tanaka
  37. Article
    Editorial: Case reports in neuroimaging and stimulation
    Dr. Masaru Tanaka
  38. Article
    Unraveling the Neurobiological Roots of Despair: Insights from Novel Kynurenine Aminotransferase II Knockout Mice
    Dr. Masaru Tanaka
  39. Article
    Editorial: Insights into structural and functional organization of the brain: evidence from neuroimaging and non-invasive brain stimulation techniques
    Dr. Masaru Tanaka
  40. Article
    Preclinical modeling in depression and anxiety: Current challenges and future research directions
    Dr. Masaru Tanaka
  41. Article
    The Tryptophan-Kynurenine Metabolic System Is Suppressed in Cuprizone-Induced Model of Demyelination Simulating Progressive Multiple Sclerosis
    Dr. Masaru Tanaka
  42. Article
    Exploring Novel Therapeutic Targets in the Common Pathogenic Factors in Migraine and Neuropathic Pain
    Dr. Masaru Tanaka
  43. Article
    Exploring Novel Therapeutic Targets in the Common Pathogenic Factors in Migraine and Neuropathic Pain
    Dr. Masaru Tanaka
  44. Article
    Integrating Armchair, Bench, and Bedside Research for Behavioral Neurology and Neuropsychiatry: Editorial
    Dr. Masaru Tanaka
  45. Article
    Single Nucleotide Polymorphisms of Indoleamine 2,3-Dioxygenase 1 Influenced the Age Onset of Parkinson's Disease
    Dr. Masaru Tanaka
  46. Article
    Mitochondrial Impairment: A Common Motif in Neuropsychiatric Presentation? The Link to the Tryptophan–Kynurenine Metabolic System
    Dr. Masaru Tanaka
  47. Article
    Mitochondrial Impairment: A Common Motif in Neuropsychiatric Presentation? The Link to the Tryptophan-Kynurenine Metabolic System
    Dr. Masaru Tanaka
  48. Article
    Crosstalk between Depression, Anxiety, and Dementia: Comorbidity in Behavioral Neurology and Neuropsychiatry
    Dr. Masaru Tanaka
  49. Article
    Editorial of Special Issue ‘Dissecting Neurological and Neuropsychiatric Diseases: Neurodegeneration and Neuroprotection’
    Dr. Masaru Tanaka
  50. Article
    Modelling the neurodevelopmental pathogenesis in neuropsychiatric disorders. Bioactive kynurenines and their analogues as neuroprotective agents—in celebration of 80th birthday of Professor Peter Riederer
    Dr. Masaru Tanaka
  51. Article
    Memory Enhancement with Kynurenic Acid and Its Mechanisms in Neurotransmission
    Dr. Masaru Tanaka
  52. Article
    Memory Enhancement with Kynurenic Acid and its Mechanisms in Neurotransmission
    Dr. Masaru Tanaka
  53. Article
    Novel Pharmaceutical Approaches in Dementia
    Dr. Masaru Tanaka
  54. Article
    Neurogenic Inflammation: The Participant in Migraine and Recent Advancements in Translational Research
    Dr. Masaru Tanaka
  55. Article
    Neurogenic Inflammation: One of the Participants of Migraine and the Contribution of Translational Research
    Dr. Masaru Tanaka
  56. Article
    Monitoring the kynurenine system: Concentrations, ratios or what else?
    Dr. Masaru Tanaka
  57. Article
    Co-Players in Chronic Pain: Neuroinflammation and the Tryptophan-Kynurenine Metabolic Pathway
    Dr. Masaru Tanaka
  58. Article
    Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway
    Dr. Masaru Tanaka
  59. Article
    Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway
    Dr. Masaru Tanaka
  60. Article
    Co-Players in Chronic Pain: Neuroinflammation and the Tryptophan-Kynurenine Metabolic Pathway
    Dr. Masaru Tanaka
  61. Article
    Single Nucleotide Polymorphisms of Indoleamine 2,3-Dioxygenase Influenced the Age Onset of Parkinson’s Disease
    Dr. Masaru Tanaka
  62. Article
    Antidepressant-like Effects of Kynurenic Acid Analogues
    Dr. Masaru Tanaka
  63. Article
    Editorial of Special Issue “Crosstalk between Depression, Anxiety, and Dementia: Comorbidity in Behavioral Neurology and Neuropsychiatry”
    Dr. Masaru Tanaka
  64. Article
    Are 5-HT1 receptor agonists effective anti-migraine drugs?
    Dr. Masaru Tanaka
  65. Article
    Crosstalk between Existential Phenomenological Psychotherapy and Neurological Sciences in Mood and Anxiety Disorders
    Dr. Masaru Tanaka
  66. Article
    Crosstalk between Existential Phenomenological Psychotherapy and Neurological Science in Mood and Anxiety Disorders
    Dr. Masaru Tanaka
  67. Article
    Crosstalk between Existential Phenomenological Psychotherapy and Neurological Science in Mood and Anxiety Disorders
    Dr. Masaru Tanaka
  68. Article
    Novel Pharmaceutical Approaches in Dementia
    Dr. Masaru Tanaka
  69. Article
    Crosstalk between Existential Phenomenological Psychotherapy and Neuroscience in Mood and Anxiety Disorders
    Dr. Masaru Tanaka
  70. Article
    Searching for Peripheral Biomarkers in Neurodegenerative Diseases: The Tryptophan-Kynurenine Metabolic Pathway
    Dr. Masaru Tanaka
  71. Article
    Searching for Peripheral Biomarkers in Neurodegenerative Diseases: The Tryptophan-Kynurenine Metabolic Pathway
    Dr. Masaru Tanaka
  72. Article
    Monitoring the Redox Status in Multiple Sclerosis
    Dr. Masaru Tanaka
  73. Article
    Single Nucleotide Polymorphisms of Indoleamine 2,3-Dioxygenase Influenced the Age Onset of Parkinson’s Disease
    Dr. Masaru Tanaka
  74. Article
    Monitoring the Redox Status in Multiple Sclerosis
    Dr. Masaru Tanaka
  75. Article
    Single Nucleotide Polymorphisms of Indoleamine 2,3-Dioxygenase 1 Influenced the Age Onset of Parkinson’s Disease
    Dr. Masaru Tanaka
  76. Article
    Monitoring the Redox Status in Multiple Sclerosis
    Dr. Masaru Tanaka
  77. Article
    Monitoring the Redox Status in Multiple Sclerosis
    Dr. Masaru Tanaka
  78. Article
    Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines
    Dr. Masaru Tanaka
  79. Article
    Antidepressant-like effects of kynurenic acid in a modified forced swim test
    Dr. Masaru Tanaka
  80. Article
    Are Kynurenines Accomplices or Principal Villains in Dementia? Maintenance of Kynurenine Metabolism
    Dr. Masaru Tanaka
  81. Article
    Short analogs and mimetics of human urocortin 3 display antidepressant effects in vivo
    Dr. Masaru Tanaka
  82. Article
    Neuropeptide AF induces anxiety-like and antidepressant-like behavior in mice
    Dr. Masaru Tanaka
  83. Article
    Neurotransmissions of antidepressant-like effects of neuromedin U-23 in mice
    Dr. Masaru Tanaka
  84. Article
    Neurotransmissions of antidepressant-like effects of kisspeptin-13
    Dr. Masaru Tanaka
  85. Article
    Neurotransmission of the antidepressant-like effects of the growth hormone-releasing hormone antagonist MZ-4-71
    Dr. Masaru Tanaka
  86. Article
    Effects of the growth hormone-releasing hormone (GH-RH) antagonist on brain functions in mice
    Dr. Masaru Tanaka
  87. Article
    Antidepressant-like effects of urocortin 3 fragments
    Dr. Masaru Tanaka
  88. Article
    Effects of the LHRH antagonist Cetrorelix on affective and cognitive functions in rats
    Dr. Masaru Tanaka
  89. Article
    Effects of the LHRH antagonist Cetrorelix on the brain function in mice
    Dr. Masaru Tanaka
  90. Article
    Involvement of adrenergic and serotonergic receptors in antidepressant-like effect of urocortin 3 in a modified forced swimming test in mice
    Dr. Masaru Tanaka
  91. Article
    Antidepressant-like effects of the CRF family peptides, urocortin 1, urocortin 2 and urocortin 3 in a modified forced swimming test in mice
    Dr. Masaru Tanaka
  92. Article
    Inhibition of Multidrug Resistance of Cancer Cells by Natural Diterpenes, Triterpenes and Carotenoids
    Dr. Masaru Tanaka
  93. Article
    MUTAGENICITY OF SYNTHETIC ACRIDINONES AND THIOACRIDINES IN DIRECT AMES' SALMONELLA MUTAGENICITY ASSAY
    Dr. Masaru Tanaka